3XZ

bis{[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl]methyl} hydrogen phosphate

Created:	2014-12-08
Last modified:	2015-07-22

Find Related PDB Entry
1 entries where 3XZ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	6
Bond Count	69
Aromatic Bond Count	20

2D diagram of 3XZ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	bis{[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl]methyl} hydrogen phosphate
Systematic Name (OpenEye OEToolkits)	bis[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-oxidanyl-oxolan-2-yl]methyl] hydrogen phosphate
Formula	C₂₀ H₂₅ N₁₀ O₈ P
Molecular Weight	564.448
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=P(OCC3OC(n1c2ncnc(N)c2nc1)CC3O)(O)OCC6OC(n5cnc4c(ncnc45)N)CC6O
SMILES	CACTVS	3.385	Nc1ncnc2n(cnc12)[CH]3C[CH](O)[CH](CO[P](O)(=O)OC[CH]4O[CH](C[CH]4O)n5cnc6c(N)ncnc56)O3
SMILES	OpenEye OEToolkits	1.9.2	c1nc(c2c(n1)n(cn2)C3CC(C(O3)COP(=O)(O)OCC4C(CC(O4)n5cnc6c5ncnc6N)O)O)N
Canonical SMILES	CACTVS	3.385	Nc1ncnc2n(cnc12)[C@H]3C[C@H](O)[C@@H](CO[P](O)(=O)OC[C@H]4O[C@H](C[C@@H]4O)n5cnc6c(N)ncnc56)O3
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1nc(c2c(n1)n(cn2)[C@H]3C[C@@H]([C@H](O3)COP(=O)(O)OC[C@@H]4[C@H](C[C@@H](O4)n5cnc6c5ncnc6N)O)O)N
InChI	InChI	1.03	InChI=1S/C20H25N10O8P/c21-17-15-19(25-5-23-17)29(7-27-15)13-1-9(31)11(37-13)3-35-39(33,34)36-4-12-10(32)2-14(38-12)30-8-28-16-18(22)24-6-26-20(16)30/h5-14,31-32H,1-4H2,(H,33,34)(H2,21,23,25)(H2,22,24,26)/t9-,10-,11+,12+,13+,14+/m0/s1
InChIKey	InChI	1.03	PPQXTUORNPDZDR-PRSXHHODSA-N

Related Resource References

Resource Name	Reference
PubChem	101440379

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.